The role of phenylalanine at position 6 in glucagon's mechanism of biological action: Multiple replacement analogues of glucagon

Journal of Medicinal Chemistry

Volumn 40, Issue 16, 1997, Pages 2555-2562

  Azizeh, Bassem Y ^a,b   Ahn, Jung Mo ^a   Caspari, Rael ^a   Shenderovich, Mark D ^a   Trivedi, Dev ^a   Hruby, Victor J ^a  

^a University of Arizona ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; PHENYLALANINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; DOSE RESPONSE; HYDROPHILICITY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; GLUCAGON; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENYLALANINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030837496     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960800d     Document Type: Article

References (46)

1. McKee, R. L.; Pelton, J. T.; Trivedi, D.; Johnson, D. G.; Coy, D. H.; Sueiras-Diaz, J.; Hruby, V. J. Receptor Binding and Adenylate Cyclase Activities of Glucagon Analogues Modified in the N-Terminal Region. Biochemistry 1986, 25, 1650-1656.
2. Hruby, V. J. Strategies in the Development of Peptide Antagonists. In Progress in Brain Research; Joosse, J., Buijis, R. M., Tilders, F. J. H., Eds.; Elsevier Science Publishers: Amsterdam, 1992; Vol. 92, pp 215-224.
3. Unger, R. H. Role of Glucagon in the Pathogenesis of Diabetes: The Status of the Controversy. Metabolism 1978, 27, 1691-1709.
4. Unger, R. H.; Orci, L. The Essential Role of Glucagon in the Pathogenesis of Diabetes Mellitus. Lancet 1975, No. 1, 14-26.
5. Unger, R. H.; Orci, L. Role of Glucagon in Diabetes Mellitus. Arch. Intern. Med. 1977, 137, 482-491.
6. Johnson, D. G.; Goebel, C. U.; Hruby, V. J.; Bregman, M. D.; Trivedi, D. Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist. Science 1982, 215, 1115-1116.
7. Bregman, M. D.; Trivedi, D.; Hruby, V. J. Glucagon Amino Groups. Evaluation of Modifications Leading to Antagonism and Agonism. J. Biol. Chem. 1980, 255, 11725-11731.
8. 2 Identifies Glucagon Antagonists from Weak Partial Agonists/Antagonists. Endocrinology 1996, 137, 3316-3322.
9. 9]-Glucagon Amide: A Newly Designed "Pure" Glucagon Antagonist. Bioorg. Med. Chem. Lett. 1995, 5, 1849-1852.
10. 9]Glucagon Amide, a Glucagon Antagonist. Peptides 1989, 10, 1171-1177.
11. Jelinek, L. J.; Lok, S.; Rosenberg, G. B.; Smith, R. A.; Grant, F. J.; Biggs, S.; Bensch, P. A.; Kuijper, J. L.; Sheppard, P. O.; Sprecher, C. A.; O'Hara, P. J.; Foster, D.; Walker, K. M.; Chen, L. H. J.; McKernan, P. A.; Kindsvogel, W. Expression Cloning and Signaling Properties of the Rat Glucagon Receptor. Science 1993, 259, 1614-1616.
12. Zechel, C.; Trivedi, D.; Hruby, V. J. Synthetic Glucagon Antagonists and Partial Agonists. Int. J. Pept. Protein Res. 1991, 38, 131-138.
13. Braun, W.; Wider, G.; Lee, K. H.; Wuthrich, K. Conformation of Glucagon in a Lipid-Water Interface by 1H Nuclear Magnetic Resonanse. J. Mol. Biol. 1983, 169, 921-948.
14. Sasaki, K.; Dockerill, S.; Adamiak, D. A.; Tickle, I. J.; Blundell, T. X-Ray Analysis of Glucagon and its Relationship to Receptor Binding. Nature (London) 1975, 257, 751-757.
15. Campbell, R. M.; Scanes, C. G. Evolution of the Growth Hormone-Releasing Factor (GRF) Family of Peptides. Growth Regul. 1992, 2, 175-191.
16. 27)-Glucagon. Biochemistry 1975, 14, 1559-1563.
17. Hruby, V. J.; Krystenansky, J. L.; Gysin, B.; Pelton, J. T.; Trivedi, D.; McKee, R. L. Conformational Considerations in the Design of Glucagon Agonists and Antagonists: Examination Using Synthetic Analogs. Biopolymers 1986, 25, S135-S155.
18. Hruby, V. J. Structure-Conformation-Activity Studies of Glucagon and Semi-Synthetic Glucagon Analogs. Mol. Cell. Biochem. 1982, 44, 49-64.
19. Unson, C. G.; MacDonald, D.; Ray, K.; Durrah, T. L.; Merrifield, R. B. Position 9 Replacement Analogs of Glucagon Uncouple Biological Activity and Receptor Binding. J. Biol. Chem. 1991, 266, 2763-2766.
20. Unson, C. G.; MacDonald, D.; Merrifield, R. B. The Role of Histidine-1 in Glucagon Action. Arch. Biochem. Biophys. 1993, 300, 747-750.
21. Unson, C. G.; Andreu, D.; Gurzenda, E. M.; Merrifield, R. B. Synthetic Peptide Antagonists of Glucagon. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 4083-4087.
22. Fields, G. B; Noble, R. L. Solid Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonyl Amino Acids. Int. J. Pept. Protein Res. 1990, 35, 161-214.
23. Dharanipragada, R.; Trivedi, D.; Bannister, A.; Siegel, M.; Toutwe, D.; Mollova, N.; Schram, K.; Hruby, V. J. Synthetic Linear and Cyclic Glucagon Antagonists. Int. J. Pept. Protein Res. 1993, 42, 68-77.
24. Korn, A. P.; Ottensmeyer, F. P. A Model for the Three-Dimensional Structure of Glucagon. J. Theor. Biol. 1983, 105, 403-425.
25. Merrifield, R. B. Solid Phase Peptide Synthesis. The Synthesis of a Tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154.
26. Hruby, V. J.; Krystenanky, J. L.; McKee, R. L.; Pelton, J. T. Glucagon Structure-Function Relationships. The Use of Glucagon Analogues in Studies of Glucagon Receptor Interactions. Hormonal Control of Gluconeogenesis. In Signal Transmission; Kraus-Friedmann, N., Ed.; CRC Press: Boca Raton, FL, 1986; pp 3-20.
27. Krystenansky, J. L.; Trivedi, D.; Johnson, D.; Hruby, V. J. Conformational Considerations in the Design of a Glucagon Analogue with Increased Receptor Binding and Adenylate Cyclase Potencies. J. Am. Chem. Soc. 1986, 108, 1696-1698.
28. Azizeh, B. Y.; Shenderovich, M. D.; Trivedi, D.; Li, G.; Sturm, N. S.; Hruby, V. J. Topographical Amino Acid Substitution in Position 10 of Glucagon Leads to Antagonists/Partial Agonists with Greater Binding Differences. J. Med. Chem. 1996, 39 2449-2455.
29. Krystenansky, J. L.; Trivedi, D.; Hruby, V. J. Importance of the 10-13 Region of Glucagon for Its Receptor Interactions and Activation of Adenylate Cyclase. Biochemistry 1986, 25, 3833-3839.
30. Unson, C. G.; Wu, C.-R.; Fitzpatrick, K. F.; Merrifield, R. B. Multiple-Site Replacement Analogs of Glucagon. J. Biol. Chem. 1994, 269, 12548-12551.
31. Gratzer, W. B.; Creeth, J. M.; Beaven, G. H. Presence of Trimers in Glucagon Solution. Eur. J. Biochem. 1972, 31, 505-509.
32. Formisano, S.; Johnson, M. L.; Edelhoch, H. Thermodynamics of the Self-Association Glucagon. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 3340-3344.
33. Bösch, C.; Brown, L. R.; Wüthrich, K. Physicochemical Characterization of Glucagon-Containing Lipid Micelles. Biochim. Biophys. Acta 1980, 603, 298-312.
34. Guarnieri, F.; Still, W. C. A Rapidly Convergent Simulation Method: Mixed Monte Carlo/Stochastic Dynamics. J. Comput. Chem. 1994, 15, 1302-1310.
35. Weiner, S. J.; Kollman, P. A.; Case, D. A. All-Atom Force Field for Simulations of Proteins and Nucleic Acids. J. Comput. Chem. 1986, 7, 230-252.
36. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C.; MacroModel-An Integrated Software System for Modeling Organic and Bioorganic Molecules Using Molecular Mechanics. J. Comput. Chem. 1990, 11, 440-467.
37. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics. J. Am. Chem. Soc. 1990, 112, 61127-6129.
38. 9]Glucagon amide, a Peptide Antagonist of the Glucagon Receptor System. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1662-1666.
39. Hruby, V. J.; Gysin, B.; Trivedi, D. B.; Johnson, D. G. New Glucagon Analogues With Conformational Restrictions and Altered Amphiphilicity: Effects on Binding, Adenylate Cyclase and Glycogenolytic Activities. Life Sci. 1993, 52, 845-855.
40. Lundt, B. F.; Johansen, N. L.; Volund, A.; Markussen, J. Removal of t-Butyl and t-Butoxycarbonyl Protecting Groups with Trifluoroacetic Acid. Int. J. Pept. Protein Res. 1978, 12, 258-268.
41. Neville, D. M., Jr. Isolation of an Organ Specific Protein Antigen from Cell Surface Membrane of Rat Liver. Biochim. Biophys. Acta 1968, 154, 540-552.
42. Pohl, S. L.; Birnbaumer, L.; Rodbell, M. The Glucagon-Sensitive Adenylate Cyclase System in Membranes of Rat Liver. Comparison Between Glucagon- and Fluoride-Stimulated Activities. J. Biol. Chem. 1971, 246, 1857-1860.
43. Markwell, M. A. K.; Haas, S. M.; Bieleer, L. L.; Tolbert, N. E. A Modification of the Lowry Procedure to Simplify Protein Determination in Membrane and Lipoprotein Samples. Anal. Biochem. 1978, 87, 206-210.
44. 1-6 Binds to the Glucagon Receptor and Activates Hepatic Adenylate Cyclase. J. Biol. Chem. 1979, 254, 268-269.
45. Salomon, Y.; Londos, G.; Rodbell, M. J. A Highly Sensitivity Adenylate Cyclase Assay. Anal. Biochem. 1974, 58, 541-548.
46. Schild, H. O. A New Scale for the Measurement of Drug Antagonism. Br. J. Pharmacol. 1947, 2, 189-207.